HHS Announces $25M Contract For Ebola Drug Research; CDC Asks U.S. Colleges To Take Precautions

News outlets report on U.S. health agencies’ actions in light of the West African Ebola outbreak.

CQ HealthBeat: HHS Boosts Ebola Drug Development, but Not Fast Enough to Stop Outbreak
“Federal officials announced Tuesday a $25 million contract to accelerate development of the drug that has performed spectacularly to stop Ebola in limited animal testing. But an infectious diseases specialist warned that even if it works well in humans, the compound can’t be made quickly enough to alter the course of the current epidemic in West Africa…” (Reichard, 9/2).

New York Times: U.S. Health Agency Advises More Vigilance on Campuses
“The Centers for Disease Control and Prevention has advised American colleges and universities, and any students or staff arriving from nations hit by the Ebola virus, to take precautions against spreading the disease that go beyond what most schools have done…” (Pérez-Peña, 9/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.